TerminatedInterventionalPhase 2Updated Aug 12, 2021
Vitamin and Asthma Study | NCT01447173 | Trialant
CompletedInterventionalPhase 4Updated Oct 23, 2012
Vitamin and Asthma Study
ClinicalTrials.gov ID
NCT01447173
Lead Sponsor
Augusta UniversityOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
10Actual
Last Update Posted
Oct 23, 2012Estimated
Start Date
Dec 2010
Primary Completion Date
Sep 2011Actual
Completion Date
Sep 2011Actual
Brief Summary
The study looks at how vitamin D supplement will improve the severity of asthma and lung function as well as biomarkers in asthmatic children.
Asthma
Vitamin D
Ages Eligible for Study
Child (0-17)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
History of asthma (under control)otherwise in good general health
Exclusion Criteria:
Poorly controlled asthma
Taking daily multivitamin or vitamin D supplementation
Taking oral steroid medication
History of bronchopulmonary dysplasia or chronic lung disease, extreme prematurity, congenital heart disease, significant renal dysfunction or primary kidney disease, endocrinologic abnormalities of calcium metabolism or parathyroid disorders
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
Pediatrics Allergy Clinic at Georgia Health Sciences University